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Abstract
Introduction Cardiac surgery using cardiopulmonary bypass in
newborns, infants and small children often requires
intraoperative red blood cell transfusions to prime the circuit and
oxygenator and to replace blood lost during surgery. The
purpose of this study was to investigate the influence of red
blood cell storage time prior to transfusion on postoperative
morbidity in pediatric cardiac operations.
Methods One hundred ninety-two consecutive children aged
five years or less who underwent cardiac operations using
cardiopulmonary bypass and who received red blood cells for
priming the cardiopulmonary bypass circuit comprised the
blood-prime group. Forty-seven patients receiving red blood cell
transfusions after cardiopulmonary bypass were separately
analyzed. Patients in the blood-prime group were divided into
two groups based on the duration of storage of the red blood
cells they received. The newer blood group included patients
who received only red blood cells stored for less than or equal
to four days and the older blood group included patients who
received red blood cells stored for more than four days.
Results Patients in the newer blood group had a significantly
lower rate of pulmonary complications (3.5% versus 14.4%; P
= 0.011) as well as a lower rate of acute renal failure (0.8%
versus 5.2%; P = 0.154) than patients in the older blood group.
Major complications (calculated as a composite score based on
pulmonary, neurological, and gastroenterological complications,
sepsis and acute renal failure) were found in 6.9% of the
patients receiving newer blood and 17.1% of the patients
receiving older blood (P  = 0.027). After adjusting for other
possible confounding variables, red blood cell storage time
remained an independent predictor of major morbidity. The
same association was not found for patients receiving red blood
cell transfusions after cardiopulmonary bypass.
Conclusions The storage time of the red blood cells used for
priming the cardiopulmonary bypass circuit in cardiac
operations on newborns and young infants is an independent
risk factor for major postoperative morbidity. Pulmonary
complications, acute renal failure, and infections are the main
complications associated with increased red blood cell storage
time.
Introduction
Cardiac surgery using cardiopulmonary bypass (CPB) in new-
borns, infants and small children requires the use of intraoper-
ative homologous red blood cell (RBC) transfusions in the
majority of cases. RBCs are used to prime the CPB circuit and
oxygenator (although the most recently developed oxygena-
tors require a very small priming volume) and to correct intra-
operative anemia during and after CPB.
Allogeneic RBC transfusion has more of an impact on the
physiology of pediatric patients than on adult physiology. Dur-
ing cardiac operations, patients weighing less than five kilo-
grams may receive RBC transfusions that total more than 50%
of their circulating blood volume, which is the equivalent of a
massive (more than three liters) RBC transfusion in adults. It is
well known that massive transfusions can be associated with
a number of complications, both in critically ill adult patients
and in adult patients undergoing cardiac surgery [1-3]. It is
aPTT: activated partial thromboplastin time; ARF: acute renal failure; ASD: atrial septal defect; AV: atrioventricular, CPB: cardiopulmonary bypass; 
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therefore reasonable to hypothesize that the same may hap-
pen in newborns, infants and small children undergoing car-
diac surgery using CPB.
In a recent article, Koch and coworkers [4] elegantly demon-
strated that the duration of RBC storage prior to transfusion
was independently associated with increased morbidity and
mortality in adult cardiac surgery patients as well as decreased
long-term survival. This study confirmed the results of previous
studies, which found an association between the risk of com-
plications and blood storage time [5-7].
In this study, we tested the hypothesis that among newborns,
infants and small children undergoing cardiac surgery using
CPB, the storage time of the RBCs transfused during the
operation may (i) cause changes in the metabolic profiles of
the patients during CPB and (ii) lead to differences in postop-
erative complication rates. Postoperative transfusions in
patients having undergone operations without blood prime or
intraoperative transfusions were separately addressed in a
sensitivity analysis.
Materials and methods
This retrospective study enrolled 192 consecutive newborns,
infants and small children who underwent cardiac surgery
using CPB and who required RBC transfusion to prime the
CPB circuit. A second group of 47 patients being transfused
after CPB was separately analyzed. All patients underwent
surgery at our institution between January 2006 and Decem-
ber 2008. The duration of RBC storage of the transfused
blood was not available before January 2006 in our database.
During the study period, 948 patients were operated on for
congenital heart disease at our Institution. Two hundred forty-
five were adult (>16 years) congenital patients, and 123 were
excluded because they were operated on without CPB; the
remaining 580 did not receive RBC transfusions to prime the
CPB circuit: 98 of these patients received RBC transfusions
after CPB, and the remaining were not transfused. It is our pol-
icy not to use blood prime in patients weighing more than 10
kg, unless they are severely anemic.
For patients needing a blood prime, it is our policy to ask the
blood bank to provide us with RBCs stored for less than seven
days; however, this is not mandatory, and depending on avail-
ability patients may receive RBCs stored for a longer period of
time.
The study design was approved by the local Ethics Committee
and the need for parental consent was waived given the retro-
spective nature of the study. The primary endpoint of the study
was to determine patients' morbidity based on the duration of
storage of the blood that patients received and to compare
major morbidity rates in patients receiving newer vs. older
blood. The secondary endpoint was to examine the metabolic
profile of patients during CPB based on RBC storage time.
Patients
Pediatric patients undergoing a cardiac operation using CPB
during the study period in whom RBCs were used in the prim-
ing solution of the CPB circuit were included in the blood-
prime group. The use of RBCs in the priming solution is a cur-
rent practice at our institution in cases when the use of a crys-
talloid or colloid priming solution would result in a severe
hemodilution. Patients receiving RBCs both in the priming
solution and after CPB were included in this group. Patients
receiving RBC transfusions only after CPB were separately
analyzed (post-CPB transfusion group).
Anesthesia, cardiopulmonary bypass, and cardiac 
surgery technique
Anesthesia was carried out according to our institutional prac-
tice. Induction of anesthesia was achieved with intravenous
midazolam. A high-dose opioid anesthetic (fentanyl 50 μg/kg)
was used for maintenance of anesthesia and supplemented
with midazolam and sevoflurane as tolerated. Neuromuscular
blockade was achieved with vecuronium. All patients under-
went endotracheal intubation and were mechanically venti-
lated. Standard monitoring was used, which included a radial
or femoral artery catheter for measurement of systemic arterial
blood pressure and intermittent blood sampling, a double
lumen right internal jugular or femoral central venous catheter,
and esophageal and rectal temperature probes.
Cardiac cannulation was performed after intravenous adminis-
tration of 300 IU/kg of unfractionated heparin and only after an
activated clotting time of longer than 450 seconds was
achieved. Additional heparin boluses were used to maintain an
activated clotting time in this range before and during CPB.
Double venous cannulation of the superior and inferior vena
cava was generally performed. The arterial cannula was placed
into the ascending aorta. The CPB circuit included a hollow
fiber oxygenator (Dideco D901 or D902, Sorin Group, Miran-
dola, Italy) with an arterial line filter and a centrifugal pump
(Bio-Medicus, Medtronic, Minneapolis, MN, USA).
In the blood-prime group the CPB circuit was primed with a
solution containing RBCs and a 4% albumin solution. The
solution was titrated to reach a hematocrit value of 30% once
the patient was connected to the circuit and CPB was initi-
ated. The total priming volume varied between 350 mL and
450 mL. Therefore, the amount of RBCs used in the priming
solution varied according to the patient's baseline hematocrit,
weight, and the priming volume used. In all patients, less than
a 250 mL volume of RBCs and only one bag of stored RBCs
were used for priming the circuit. Only one bag of stored
RBCs was used to prime the circuit.
Patients in the post-CPB transfusion group received a 4%
albumin solution for priming the CPB circuit. CPB flow was
targeted at 150 mL/kg and subsequently adjusted according
to the patient's temperature.Available online http://ccforum.com/content/13/6/R207
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The target patient temperature was chosen by the surgeon
based on the type of surgical procedure being performed and
personal preferences. All procedures were performed using a
regimen of mild (32°C to 34°C), moderate (26°C to 31°C), or
deep (20°C to 25°C) hypothermia. Patients were treated with
an alpha-stat strategy if mild hypothermia was used and with a
pH-stat strategy if moderate or deep hypothermia was used.
Cardiac arrest was obtained and maintained using antegrade
intermittent blood cardioplegia.
After completion of the CPB and removal of the cannulas,
heparin was reversed using protamine sulfate at a 1:1 ratio.
During and after CPB, additional RBCs were administered as
needed in order to maintain a hematocrit value within our
standard range. These additional RBCs either came from the
first blood bag or from a second blood bag. No patient
received RBCs from more than two blood bags during the
operation. No leukodepleted blood was used for intraoperative
transfusions.
Data collection
Pre- and intraoperative data were derived from our institutional
database. Data collected included age (months), weight (kilo-
grams), hematocrit (%), serum creatinine level (mg/dL), serum
bilirubin level (mg/dL), platelet count (cells/μL), prothrombin
activity (%), activated partial thromboplastin time (seconds),
antithrombin activity (%), redo operations, type of operation,
the Aristotle severity score of the operation [8], CPB duration
(minutes), priming volume (mL), lowest temperature (°C)
reached while on CPB, and lowest hematocrit (%) reached
while on CPB.
The duration of storage time of the RBCs used during and
after CPB was obtained from our computerized blood bank
files. Records of metabolic data during CPB were collected
from perfusionists' files.
After 10 minutes on CPB, the following data were collected:
arterial pH, arterial pCO2 (mmHg), and arterial base excess as
well as potassium (mEq/L), calcium (mEq/l), lactate (mmol/L),
and glucose (mg/dL) blood concentrations. The peak values of
potassium, lactate and glucose obtained during CPB were
also collected.
Outcome variables were derived from our institutional data-
base. The following variables were collected: mechanical ven-
tilation time (hours), intensive care unit (ICU) stay (hours),
blood loss (mL/12 hours), peak postoperative creatinine level
(mg/dL), and peak postoperative bilirubin level (mg/dL) as well
as the need for postoperative allogeneic RBC, fresh frozen
plasma, or platelet transfusions. Postoperative morbidity and
mortality data were also collected. Parameters collected
included data regarding low cardiac output (defined as the
need for inotropic support for more than 48 hours postopera-
tively), acute renal failure (ARF) (defined as the need for renal
replacement therapy), pulmonary complications (defined as
respiratory distress syndrome or pneumonia), neurological
complications (defined as stroke, coma, or neurologic defects
still present at hospital discharge), gastroenterological compli-
cations (defined as bleeding, necrotizing enterocolitis, or liver
failure), sepsis, and in-hospital mortality.
Major morbidity was defined as the presence of one or more
of the following: ARF, sepsis, or pulmonary, neurological, or
gastroenterological complications.
Group definitions
The patients were divided into two groups: patients receiving
newer blood and patients receiving older blood. The storage
time of the RBCs used was analyzed using the following
steps:
1. For patients receiving more than one unit of RBCs, the old-
est unit of RBCs received was used for group allocation.
2. The median value of blood storage time was assessed, and
patients were attributed to the newer blood group if they
received only blood that had been stored for a period of time
(days) equal to or shorter than the median value. Patients were
attributed to the older blood group if they received any amount
of RBC stored for a period of time longer than the median
value.
3. For analysis of the metabolic data during CPB, the same
procedure was followed, but only the unit of blood used for
priming the circuit was taken into consideration when allocat-
ing patients to groups based on the duration of RBC storage.
4. The group of patients receiving only postoperative transfu-
sions was selected based on an age range similar to the
blood-prime group.
Statistics
Continuous variables are presented as median values and
interquartile ranges, and categorical variables are presented
as numbers and/or percentages in the tables and the text. To
compare data between groups, we used two-sided tests. The
Wilcoxon rank-sum test was used to compare continuous var-
iables and Pearson's chi-square test was used to compare
categorical variables. Yates correction was applied when
appropriate.
In order to better elucidate the relationship between RBC stor-
age time and the primary endpoint variable (major morbidity),
we performed a logistic regression analysis based on the old-
est RBCs each patient received. To adjust for potential con-
founders, other pre- and intraoperative factors thought to be
associated with conditions included in the definition of majorCritical Care    Vol 13 No 6    Ranucci et al.
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morbidity were explored. A forward stepwise multivariable
logistic regression analysis was performed to detect whether
or not RBC storage time was an independent risk factor for
major morbidity. The same analysis was applied to relevant sin-
gle morbidity events.
Results
Blood-prime group
Age of RBCs used in transfusions
The median storage time of the RBCs used for priming the
CPB machine and for subsequent intraoperative transfusions
was four days (range: 1 to 18 days). The storage time of the
RBCs used only for priming the CPB machine had the same
range of values and median value. Therefore, a four-day cut-
point was used to divide patients into groups. The patients
were allocated to groups according to the storage time of the
oldest blood they received either to the newer blood group
(one to four days of storage time, N = 116) or the older blood
group (more than four days of storage time, N = 76). For the
purposes of the analysis of metabolic changes during CPB,
only the storage time of the blood used for priming the CPB
machine was considered, and the composition of the two
groups therefore differed slightly (newer blood: N = 123; older
blood: N = 69).
All patients were exposed to at least one unit of RBCs, which
was used to prime the CPB machine. One hundred eighty-
seven patients (97.4%) were exposed to a second unit of
RBC, which was used for intraoperative transfusions during or
after CPB.
Table 1 lists the demographic features, preoperative charac-
teristics, and intraoperative data for patients receiving newer
or older blood. The ages range from two days to five years. The
two groups did not differ in terms of the total number of units
of RBCs to which they were exposed or in terms of the total
volume of RBCs they were given. Patients in the older blood
group received RBCs that had been stored for a median of six
days, which was significantly longer than patients in the newer
blood group, who received blood that had been stored for a
median of three days. Patients receiving older blood had a sig-
nificantly higher preoperative hematocrit than patients receiv-
ing newer blood. No other differences were found between
the two groups.
Metabolic data during CPB
The metabolic profiles obtained from patients while on CPB
are reported in Table 2. There were no significant differences
noted between the two groups in terms of values obtained
after 10 minutes of CPB or peak values obtained during CPB.
Clinical outcomes
Fifteen patients (12.9%) experienced at least one morbidity
event in the newer blood group, and 18 (23.7%) in the older
blood group (P = 0.053).
Patients receiving older blood had a significantly higher rate of
certain complications (Figure 1). Major morbidity was found to
be present in 17.1% of the patients receiving older blood vs.
6.9% in patients receiving newer blood (P = 0.027). The pul-
monary complication rate was significantly higher in patients
receiving older blood as compared to patients receiving newer
blood (14.4% vs. 3.5%; P = 0.011). The ARF rate was 5.2%
in patients receiving older blood and 0.8% in patients receiv-
ing newer blood (P = 0.154), and the rate of infectious com-
plications was 5.5% in patients receiving older blood and
1.7% in patients receiving newer blood (P = 0.223).
Other outcome data are reported in Table 3. Patients receiving
older blood had a significantly higher rate of platelet transfu-
sions, while the other parameters did not differ significantly
between groups.
The association between RBC storage time and the primary
endpoint variable (major morbidity) was explored using a sen-
sitivity analysis, in which RBC storage time was treated as a
continuous variable. On univariate logistic regression analysis,
RBC storage time was found to be significantly associated
with major morbidity (P = 0.016). Other pre- and intraopera-
tive variables were explored for a possible association with
major morbidity. Factors found to be significantly associated
with major morbidity were preoperative hematocrit, the preop-
erative serum creatinine value, the Aristotle score, and CPB
duration. These factors were entered into a multivariable logis-
tic regression analysis along with the RBC storage time.
Through a forward stepwise process, a final multivariate model
was created in which only CPB duration and RBC storage
time remained independent predictors of major morbidity
(Table 4). Both the unadjusted and adjusted models reporting
the likelihood of major morbidity as a function of the RBC stor-
age time are included in Figure 2.
The association between RBC storage time and pulmonary
complications was addressed with the same analysis. Since it
is known that platelet transfusions may trigger pulmonary com-
plications due to the presence of plasma and the intra-pulmo-
nary accumulation, platelets were included in the multivariable
model. Again, the only independent factors for pulmonary
complications were RBC storage time and CPB duration
(Table 5). There was a non-significant (P = 0.382) trend for
association between platelet transfusions and pulmonary
complications.
Post-CPB transfusions group
Ninety-eight patients received only post-CPB RBC transfu-
sions. This group was highly non-homogeneous with respect
to the blood-prime group. They were significantly (P < 0.001)
older (46 ± 37 months vs. 9 ± 9 months), with a higher weight
(13 ± 7 kg vs. 6.5 ± 2.7 kg) and baseline hematocrit (40 ±
7.6% vs 34 ± 4.6%). To adjust for age differences, we
included in this group only patients aged five years or lessAvailable online http://ccforum.com/content/13/6/R207
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Table 1
Demographic information, preoperative profile and operative details in the blood-prime group
Variable Patients Receiving Newer Blood
(N = 116)
Patients Receiving Older Blood
(N = 76)
P value
Transfused blood
Duration of storage (days)
Median 3 6 0.001
Interquartile range 2 to 4 5 to 8
Number of red blood cell units
Median 2 2 0.985
Interquartile range 2 to 2 2 to 2
Demographic features
Age (months)
Median 6.5 8 0.089
Interquartile range 4 to 11 5 to 11
Male sex -- no. of patients (%) 68 (58) 37 (49) 0.196
Weight (kgs)
Median 6.15 6.7 0.244
Interquartile range 4. 5 to 7.6 5 to 7.7
Clinical features
Hematocrit (%)
Median 33 36 0.005
Interquartile range 31 to 36 32 to 38
Platelet count (cells/μL)
Median 321000 314000 0.903
Interquartile range 249000 to 382000 245000 to 391000
Prothrombin activity (%)
Median 84.5 84.7 0.903
Interquartile range 76 to 91 76 to 94
aPTT (seconds)
Median 31.2 31 0.724
Interquartile range 28 to 34 29 to 34
Antithrombin activity (%)
Median 105 104 0.190
Interquartile range 91 to 115 89 to 113
Creatinine (mg/dL)
Median 0.3 0.3 0.429
Interquartile range 0.25 to 0.35 0.25 to 0.35
Bilirubin (mg/dL)
Median 0.4 0.35 0.509
Interquartile range 0.27 to 0.65 0.27 to 0.54
Aristotle scoreCritical Care    Vol 13 No 6    Ranucci et al.
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(same range of the blood-prime group), sorting out 47
patients. Despite this, this group remained composed by sig-
nificantly (P < 0.001) older (38 ± 17 months) patients with
higher weight (13 ± 4 kg) and hematocrit (40.8 ± 7.8%).
Therefore, these data were not pooled together with the
blood-prime group, but analyzed separately.
The median RBC storage time was four days (range 1 to 26,
interquartile range 3 to 8). Twenty-five patients received newer
blood and 22 older blood. This group experienced fewer com-
plications than the blood-prime group, with only 4.3% of major
morbidity, 6.5% of low cardiac output, 2.1% of pulmonary
complications, 2.1% of sepsis and no mortality. No associa-
tion was found between RBC storage time and any
complication.
Discussion
Intraoperative transfusion of RBC that had been stored for
more than four days was associated with a significantly
increased risk of postoperative complications in newborns,
infants, and children aged five years or less undergoing car-
diac surgery when blood was used to prime the CPB circuit.
The pulmonary complication rate was significantly higher in
patients receiving older blood, and a higher major morbidity
rate (a measure of serious complications) was observed in
patients receiving older blood.
Median 7.5 6.3 0.803
Interquartile range 6 to 8 6 to 8
Redo operations -- no. of patients (%) 6 (5.2) 4 (5.1) 0.296
Operative details
Procedure -- no. of patients (%)
ASD repair 2 (2) 2 (3)
VSD repair 39 (34) 27 (36)
TOF correction 18 (16) 12 (16)
Arterial switch 10 (9) 10 (13)
AV canal 16 (14) 10 (13)
Others 31 (25) 16 (19)
Priming volume (mL)
Median 400 400 0.292
Interquartile range 380 to 400 380 to 400
Transfused RBC volume (mL)
Median 240 240 0.792
Interquartile range 216 to 300 240 to 300
CPB duration (minutes)
Median 82 74 0.480
Interquartile range 58 to 110 52 to 120
Lowest temperature (°C)
Median 29.6 30 0.771
Interquartile range 28.3 to 31 28 to 32
Lowest hematocrit (%)
Median 28 28 0.151
Interquartile range 26 to 29 26 to 30
aPTT = activated partial thromboplastin time; ASD = atrial septal defect; AV = atrioventricular; CPB = cardiopulmonary bypass; TOF = tetralogy 
of Fallot; VSD = ventricular septal defect.
Continuous variables are described as medians and interquartile ranges, and P values were calculated by the Wilcoxon rank-sum test; categorical 
variables are described as numbers and percentages, and P values were calculated by Pearson's chi-square test.
Table 1 (Continued)
Demographic information, preoperative profile and operative details in the blood-prime groupAvailable online http://ccforum.com/content/13/6/R207
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After adjusting for other explanatory variables, there was a sig-
nificant association found between RBC storage time and the
risk of major morbidity. The storage time of RBC used for prim-
ing the CPB circuit was not associated with metabolic
changes immediately after the onset of CPB or during the
entire course of CPB.
There is little information available in the literature about the
impact of RBC storage time on the intra- and postoperative
courses of pediatric patients undergoing CPB. Several arti-
cles [9,10] have explored the metabolic effects of using fresh
vs. older stored blood in CPB priming solution, but these stud-
ies have limited their analysis to effects observed during CPB.
Another study [11] compared blood lactate levels and clinical
Table 2
Acid-base balance, electrolyte, lactate, and glucose levels during cardiopulmonary bypass (after 10 minutes on CPB and peak levels 
recorded during CPB)
Variable Patients Receiving Newer Blood
(N = 123)
Patients Receiving Older Blood
(N = 69)
P value
pH
Median 7.41 7.42 0.432
Interquartile range 7.36 to 7.44 7.37 to 7.47
pCO2 (mmHg)
Median 42 40 0.297
Interquartile range 36 to 46 35 to 43
Base excess
Median 1.4 1.3 0.994
Interquartile range -1.2 to 4.3 -1.3 to 3.8
Potassium (mEq/L)
Median 4.7 4.6 0.387
Interquartile range 3.7 to 5.6 3.5 to 5.3
Calcium (mEq/L)
Median 1.4 1.4 0.168
Interquartile range 1.2 to 1.6 1.2 to 1.6
Lactate (mmol/L)
Median 1.8 1.9 0.127
Interquartile range 1.2 to 2.3 1.5 to 2.5
Glucose (mg/dL)
Median 142 141 0.469
Interquartile range 127 to 168 121 to 165
Peak potassium (mEq/L)
Median 5.3 5.6 0.746
Interquartile range 4.7 to 6 4.8 to 6
Peak lactate (mmol/L)
Median 1.9 2.0 0.237
Interquartile range 1.5 to 2.5 1.5 to 2.8
Peak glucose (mg/dL)
Median 175 186 0.630
Interquartile range 154 to 215 143 to 227
Variables are described as medians and interquartile ranges, and P values were calculated by the Wilcoxon rank-sum test.Critical Care    Vol 13 No 6    Ranucci et al.
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outcomes in pediatric patients treated with either blood-con-
taining or bloodless priming solutions.
There is conflicting information in the literature with respect to
metabolic changes that occur during CPB with respect to the
use of fresh or old blood. Schroeder and coworkers [10] found
that pediatric patients receiving RBC stored for more than 12
days had higher blood lactate levels and lower blood glucose
levels during CPB in comparison to patients receiving RBC
stored for 12 days or less. They identified a linear association
between RBC storage time and both blood lactate and glu-
cose levels during CPB. However, at the end of the operation,
no differences in blood lactate levels were detected. Con-
versely, Keidan and coworkers [9] did not find any metabolic
difference in blood electrolytes, lactate, or glucose levels dur-
ing CPB in patients receiving newer (storage time less than or
equal to five days) vs. older (storage time more than or equal
to five days) blood in the CPB priming solution.
Our study is in agreement with the results of Keidan and cow-
orkers but uses a model that considers both the metabolic val-
ues after the onset of CPB and the peak values obtained
during CPB. It is possible that the different cut-off values used
in various studies (we used cut-offs that were similar to those
used by Keidan and coworkers, but the cut-offs used in
Schroeder's study were much longer) may explain these differ-
ent results. However, a common finding in all of these studies
is that the blood lactate level at the end of the operation or
upon arrival in the ICU was not associated with the storage
time of the blood used in the priming solution. Moreover, there
is evidence that blood lactate levels during the ICU stay are ini-
tially higher in pediatric patients receiving a bloodless priming
solution than in those receiving a blood-containing priming
solution [11]. However, the association between early postop-
erative blood lactate levels and outcomes following pediatric
cardiac operations is still not well defined [11-13].
Figure 1
Morbidity and mortality in patients receiving newer vs. older blood in the cardiopulmonary bypass circuit Morbidity and mortality in patients receiving newer vs. older blood in the cardiopulmonary bypass circuit.Available online http://ccforum.com/content/13/6/R207
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The present study essentially confirms, in a population of new-
borns, infants and children aged five years or less and receiv-
ing cardiac operations with blood prime, the finding of Koch
and coworkers [4] that RBC storage time is an independent
predictor of morbidity. However, there are some major differ-
ences between the two studies (apart from a different sized
patient population).
(i) Cut-off values for the RBC storage time
In Koch's study, a cut-off of 15 or more days was used to
define the older blood group. This was based on previous
observations that functional and structural changes of stored
RBCs begin after two to three weeks of storage [14,15]. Inci-
dentally, this value was close to the median value for their
patient population, and the two groups were similar in num-
bers. In our study, we used the median value of the RBC stor-
age time as the cut-off point for dividing the two groups. Our
cut-off time is considerably shorter than that used by Koch et
al. but is similar to cut-offs used in other pediatric studies [9].
This is due to the generally accepted clinical practice of pref-
erentially using fresh RBCs for priming CPB circuits in this
patient population. It is our feeling that searching for a univer-
sal cut-off value for RBC storage time is useful for statistical
purposes, but somewhat arbitrary when addressing the influ-
ence of RBC storage time on postoperative outcomes. Both in
our study and in the study by Koch et al. [4], RBC storage time
was identified as an independent risk factor for morbidity even
when examined as a continuous variable. The risk of experienc-
ing an outcome included in the major morbidity definition was
found to be increased even for increased storage times below
the cut-off value. In our pediatric study, the risk of experiencing
one of these outcomes among patients receiving RBCs stored
for four days is about twice as high as that for patients receiv-
ing RBCs stored for one day. In the adult study [4], the risk of
experiencing one of the outcomes included in the definition of
composite morbidity was about 50% higher for patients
receiving RBCs stored for 14 days than for patients receiving
RBCs stored for one day.
Table 3
Outcome data for groups receiving newer vs. older blood in the blood-prime group
Variable Patients Receiving Newer Blood
(N = 116)
Patients Receiving Older Blood
(N = 76)
P value
Mechanical ventilation time (hours)
Median 48 48 0.638
Interquartile range 13 to 109 11 to 120
ICU stay (hours)
Median 96 96 0.702
Interquartile range 48 to 150 48 to 192
Peak creatinine (mg/dL)
Median 0.55 0.60 0.334
Interquartile range 0.40 to 0.90 0.40 to 0.80
Peak bilirubin (mg/dL)
Median 1.3 1.4 0.503
Interquartile range 0.62 to 2.12 0.79 to 2.00
Blood loss (mL/12 hours)
Median 70 60 0.156
Interquartile range 40 to 100 30 to 100
Red blood cells transfusions
No. of patients (%) 69 (59) 47 (62) 0.760
Fresh frozen plasma transfusions
No. of patients (%) 55 (47) 39 (51) 0.607
Platelets transfusions
No. of patients (%) 4 (3.5) 9 (12) 0.024
ICU = intensive care unit.
Continuous variables are summarized by medians and interquartile ranges, and P values were calculated by the Wilcoxon rank-sum test; 
categorical variables are summarized by numbers and percentages, and P values were calculated by the Pearson's chi-square test.Critical Care    Vol 13 No 6    Ranucci et al.
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(ii) Time-event relationship between transfusions and 
outcome
In our study, we could find a significant association between
RBC storage time and outcome only when examining the
effect of RBCs used to prime the CPB circuit. Conversely, in
Koch's study, they included RBC transfusions that occurred
throughout the entire hospital stay. We could not include
patients receiving only post-CPB RBCs transfusions in the
blood-prime group, because due to the standard practice in
cardiac surgery, patients receiving clear prime are greatly dif-
ferent for age, weight, and baseline hematocrit if compared
with patients treated with blood prime. However, in a sub-anal-
ysis of patients receiving only post-CPB transfusions we could
not find any association between RBC storage time and out-
come. There are different explanations for this finding. The
most likely is that due to the limited number of patients in this
group, and the very few adverse events, we were lacking the
power to detect differences. Moreover, we can be sure that
the events included in the major morbidity in the blood-prime
group always occurred following RBC transfusion. Con-
versely, it is possible that the complication had occurred prior
to the transfusion (and thus been a possible reason for the
transfusion), in patients receiving RBCs only after CPB. This
could explain the lack of association between the two events
in this second group.
Figure 2
Crude and adjusted likelihood of experiencing major morbidity in the group receiving blood prime Crude and adjusted likelihood of experiencing major morbidity in the group receiving blood prime.
Table 4
Multivariable logistic regression analysis for risk of major morbidity in the blood-prime group
Variable B SE OR 95% CI P value
CPB duration (minutes) 0.011 0.004 1.011 1.004 to 1.018 0.003
Blood storage time (days) 0.161 0.069 1.175 1.026 to 1.345 0.020
Constant -4.122
b = regression coefficient; C.I. = confidence interval; CPB = cardiopulmonary bypass; OR = odds ratio; SE = standard errorAvailable online http://ccforum.com/content/13/6/R207
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Finally, it is likely that old blood may be more susceptible to the
mechanical insult of CPB than new blood, and this effect is of
course lacking in patients not receiving blood prime.
In pediatric patients as well as in adult patients, the pathophys-
iological mechanisms underlying the association between
RBC storage time and adverse outcomes remains unclear.
The storage lesion that occurs in the RBC is a combination of
physical and biochemical changes, which include the deple-
tion of 2,3-diphosphoglycerate [16], the formation of proin-
flammatory cytokines [17], a decrease in RBC deformability
[14], and an increase in RBC adhesiveness and aggregability
[17]. These last two factors may contribute to impaired micro-
vascular blood flow [14,17,18], which may affect organ func-
tion, especially in the organs acting as natural filters, such as
the lung and the kidney.
It is notable that in our study, pulmonary complications were
observed significantly more frequently in patients receiving
older blood. Additionally, the rate of ARF was observed to be
higher in the same group and this difference was very close to
reaching statistical significance. These two complications
were the most important contributors to the significantly higher
major morbidity rate observed in patients receiving older
blood. Systemic infections occurred at a non-significantly
higher rate in patients receiving older blood. This could be
because the leukocytes present in the RBC units might have
had deleterious effects on the immune system, provoking a
state of immunosuppression and making individuals more sus-
ceptible to postoperative infections. The bioactive substances
released by leukocytes may be responsible for this effect.
Since there is a time-dependent accumulation of these sub-
stances in blood components during storage, individuals
receiving blood stored for a longer period of time may have a
higher susceptibility to infection than individuals receiving
blood stored for a shorter period of time. An association
between RBC storage time and infection rates has been found
by other authors in adult patient populations [4,5,19].
Limitations of this study
The main limitation of this study is the relatively small study
population. However, studies addressing outcomes after car-
diac operations in pediatric patients aged five years or less
cannot include as many patients population as studies
focused on adult patients because the overall population size
is smaller. The population size of the present study was large
enough to explore morbidity, but not mortality. The fact that
even with a limited number of patients and events we could
identify significant associations between morbidity outcome
variables and RBC storage time is probably due to the large
impact that one or two units of stored RBCs may have in
patients with a small body surface area. Even one or two units
of RBCs can be considered a massive transfusion in very small
pediatric patients.
A second limitation of the study is related to the impossibility
of exploring the role of leukodepleting techniques with respect
to the effects of RBC transfusions in this retrospective patient
sample. All our patients received non-leukodepleted blood.
However, the role of leukodepletion in limiting the adverse
effects of RBC transfusions is still unclear and a benefit has
not been demonstrated in pediatric patients undergoing car-
diac surgery. Additionally, in Koch's study, patients receiving
older blood had significantly worse outcomes despite receiv-
ing leukodepleted blood at a significantly higher rate than
patients receiving newer blood.
Conclusions
The storage time of RBCs used for priming the CPB circuit
during cardiac operations is associated with increased major
morbidity and primarily affects pulmonary and renal function.
There is a significant association between the storage time of
RBCs and the risk of experiencing a serious postoperative
complication. This risk increases with increasing storage time
even within the group of patients receiving newer (less than
five-day-old) blood. Therefore, the use of the freshest possible
blood is suggested for priming the CPB circuit. We could not
identify the same association between RB storage time and
bad outcomes in patients being transfused but not receiving
blood prime. A further study including a larger patient popula-
tion is needed to address this point.
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Table 5
Multivariable logistic regression analysis for risk of pulmonary complications in the blood-prime group
Variable B SE OR 95% CI P value
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Platelet transfusion 0.830 0.848 2.293 0.435 to 12.09 0.328
Constant -4.9
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Key messages
￿  In a population of pediatric patients including newborns, 
infants, and children aged five years or less undergoing 
cardiac operations with CPB and receiving RBCs to 
prime the CPB circuit the RBC storage time is associ-
ated with an increased morbidity rate.
￿  Patients receiving older (more than four days storage 
time) blood had a higher rate of pulmonary complica-
tions and major morbidity.
￿  After correction for confounding factors, RBC storage 
time remains independently associated with pulmonary 
complications and major morbidity.
￿  This association was not found in a population of 
patients of the same age not receiving blood prime but 
being transfused after CPB.